Tech-backed serious kidney ailment and conclude-phase renal condition administration enterprise Monogram Wellbeing declared it scored a whopping $375 million in expansion funding.
Strategic investors in the round contain CVS Well being, Humana, SCAN Wellness Strategy, Cigna Ventures and Memorial Hermann Health Process. Other participants include Initially Cressey Ventures, TPG Capital, Pura Vida Investments, Northwest Ventures Companions, and Heritage Group.
Monogram partners with health and fitness plans to give their customers a variety of renal treatment solutions, like predictive algorithms that recognize at-threat members. It also delivers at-residence and digital treatment delivered by Monogram’s clinical crew, treatment administration know-how, individualized care pathways, scientific decision guidance software, remote affected individual checking abilities and applications to produce benefit-centered treatment contracts.
The Nashville-primarily based business will use the resources to deploy its scientific products and services and its shipping and delivery model for in-home kidney and serious affliction treatment.
“This most recent milestone expansion funding round with substantive new and current companions is driven by our disciplined motivation to, and demonstration of, outstanding clinical final results. These better top quality results for patients are produced feasible by our transformative tactic to featuring in-property, proof-based mostly nephrology and polychronic care. I’m proud to work together with Monogram’s centered management crew to proceed to propel the enterprise as the sustainable medical chief for sufferers throughout the United States,” Dr. Bill Frist, Monogram’s board chair and partner with Frist Cressey Ventures, stated in a statement.
Current market SNAPSHOT
In 2021, Monogram shut a $160 million Series B funding spherical, which the organization stated would be utilized to fund its enlargement.
The enterprise has considering that extra various gamers to its executive leadership staff and its board, such as Bhavesh Shah as main money officer Karen Abbott as chief administrative officer and main compliance officer Kyle Cooksey as senior vice president of marketing and advertising and communications and Seema Verma, previous administrator of the Centers for Medicare and Medicaid Solutions, as a board member.
In October, Humana, a strategic investor in the hottest funding round, announced a benefit-based treatment settlement with Monogram Wellbeing to provide in-residence kidney treatment to its Medicare Advantage HMO and PPO plan members in Tennessee, Alabama, Mississippi and Louisiana.
The company also announced a collaboration with wellbeing and wellbeing firm Level32Wellness in October, and, in December, unveiled its partnership with faith-based mostly healthcare technique AdventHealth.
More Stories
Everything you need to know about psoriasis
A Review Of WiseHuman’s Advanced Gut Care+ Probiotic
Common Diseases and Their Vaccines